Asarina Pharma AB (publ) releases Annual Report 2022
(Stockholm, 28 April 2023) Asarina Pharma’s 2022 Annual Report contains analysis and insights into its recent positive Phase IIa results for Tourette syndrome, as well… Read More »Asarina Pharma AB (publ) releases Annual Report 2022